Whilst HA is a diagnostic marker for Alzheimer’s disease [34], we do not wish to claim subjects in our sample had specific markers of Alzheimer’s pathology in the absence of knowledge of tau or amyloid status. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.